Transition report pursuant to Rule 13a-10 or 15d-10

Revisions of Financial Statements for the Fiscal Quarters during Fiscal Year 2020 (Details)

v3.21.1
Revisions of Financial Statements for the Fiscal Quarters during Fiscal Year 2020 (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Cost of revenue     $ 3,141,041 $ 2,994,940 $ 6,209,724 $ 4,633,844
Gross profit     4,683,743 3,504,153 6,363,552 6,189,273
Product development     3,166,088 1,234,403 3,206,310 5,565,097
Net loss     $ (16,966,149) $ (6,090,027) $ (16,384,104) $ (12,403,215)
Net loss per share     $ (1.06) $ (0.56) $ (1.31) $ (2.05)
As Reported [Member]            
Cost of revenue $ 1,420,909 $ 1,638,840   $ 3,036,201    
Gross profit 1,649,637 1,667,363   3,462,892    
Product development 1,632,353 1,261,509   2,392,389    
Selling, general and administrative 5,500,837 4,796,404   8,380,219    
Net loss $ (5,348,980) $ (4,338,536)   $ (7,184,607)    
Net loss per share $ (0.43) $ (0.40)   $ (0.66)    
Adjustment [Member]            
Cost of revenue $ (24,690) $ (23,601)   $ (41,261)    
Gross profit 24,690 23,601   41,261    
Product development (757,566) (638,008)   (1,157,986)    
Selling, general and administrative 177,405 86,768   104,667    
Net loss $ 604,851 $ 574,841   $ 1,094,580    
Net loss per share      
As Revised [Member]            
Cost of revenue $ 1,396,219 $ 1,615,239   $ 2,994,940    
Gross profit 1,674,327 1,690,964   3,504,153    
Product development 874,787 623,501   1,234,403    
Selling, general and administrative 5,678,242 4,883,172   8,484,886    
Net loss $ (4,744,129) $ (3,763,695)   $ (6,090,027)    
Net loss per share $ (0.38) $ (0.34)   $ (0.56)